I'm LongbridgeAI, I can summarize articles.TRex Bio (TRXB.US) tumbled more than 16% during regular trading to $11.43.
The biotechnology industry index fell 1.4% over the same period.
The company reported a year-over-year decline in third-quarter earnings per share.
Separately, TRex Bio disclosed fiscal 2026 third-quarter revenue of $0.
Based on public media reports. AI-generated; not investment advice.
